Stem Cell Transplantation at Karolinska University Hospital provides specialist treatment for selected patients with blood cancers, bone marrow disorders, and other conditions where stem cell transplantation may be clinically appropriate. Treatment planning includes detailed assessment of the patient's diagnosis, disease status, overall health, previous treatment, transplant eligibility, and potential risks and benefits.
Price on Request
The cost of stem cell transplantation varies depending on the underlying condition, transplant type, donor requirements, diagnostic testing, conditioning treatment, hospitalization, supportive care, medications, and follow-up requirements. A personalized cost estimate can be provided after appropriate medical assessment.
Stem cell transplantation is a specialized treatment in which blood-forming stem cells are administered to restore or replace bone marrow function after intensive treatment.
Depending on the patient's condition, transplantation may involve the patient's own stem cells or stem cells obtained from a suitable donor.
Before transplantation, patients undergo detailed medical and disease assessment to determine whether the procedure is appropriate.
The evaluation may include blood tests, imaging, organ-function assessment, disease-specific investigations, and review of previous treatments.
Autologous transplantation uses the patient's own previously collected stem cells.
This approach may be considered for selected hematological conditions when high-dose treatment followed by stem cell rescue is appropriate.
Allogeneic transplantation uses blood-forming stem cells from a donor.
The donor may be related or unrelated, depending on compatibility and availability. This approach may be considered for selected blood cancers and bone marrow disorders.
For allogeneic transplantation, donor compatibility is an important part of treatment planning.
Potential donors may undergo appropriate evaluation and compatibility testing to determine whether they are suitable for donation.
Before stem cells are administered, patients may receive conditioning treatment designed to prepare the body and bone marrow for transplantation.
The type and intensity of conditioning depend on the patient's diagnosis, transplant strategy, overall health, and clinical circumstances.
For autologous transplantation, stem cells may be collected from the patient's blood following appropriate preparation.
For donor transplantation, stem cells are collected from the selected donor using an appropriate collection method.
During transplantation, the collected stem cells are administered through an intravenous route.
The cells then travel to the bone marrow, where they can begin producing new blood cells. Patients require close medical monitoring during and after the procedure.
Following transplantation, patients require regular monitoring of blood counts, organ function, infection risk, treatment response, and other potential complications.
The intensity and duration of follow-up depend on the transplant type and individual clinical circumstances.
After transplantation, the immune system may be significantly weakened, particularly during the early recovery period.
Supportive care may include infection prevention, monitoring, transfusion support, medication management, nutritional support, and treatment of complications when required.
Patients receiving allogeneic stem cells may be at risk of graft-versus-host disease, in which donor immune cells react against the recipient's tissues.
The medical team monitors for signs of this complication and provides appropriate management when necessary.
Stem cell transplantation may be considered for selected patients with high-risk or relapsed blood cancers and other serious hematological conditions.
Eligibility depends on disease characteristics, previous treatment, overall health, and expected treatment benefits.
Stem cell transplantation requires coordinated care involving hematologists, transplant specialists, laboratory teams, pharmacists, nurses, and other healthcare professionals.
Multidisciplinary management supports preparation, transplantation, monitoring, and long-term follow-up.
Patients may require ongoing follow-up after transplantation to monitor blood counts, immune recovery, organ function, disease status, medication requirements, and other potential long-term effects.
Follow-up schedules are individualized according to the transplant type and patient's clinical needs.
Patients who have been advised to undergo stem cell transplantation may seek a specialist second opinion regarding eligibility, transplant type, donor options, treatment strategy, or potential alternatives.
Previous medical records and transplant assessments can assist with specialist review.
International patients may be considered for stem cell transplantation subject to applicable eligibility, referral, appointment, and hospital requirements.
Detailed medical records, pathology reports, laboratory results, imaging studies, previous treatment information, and transplant-related assessments may be required before treatment planning.
Specialist assessment for transplant eligibility
Autologous and allogeneic transplant evaluation when appropriate
Detailed donor and compatibility assessment
Individualized conditioning and transplant planning
Specialist monitoring during recovery
Infection prevention and supportive care
Management of transplant-related complications
Long-term hematology and transplant follow-up
Karolinska University Hospital provides specialist hematology and transplant care within an academic healthcare environment. Patients requiring stem cell transplantation may benefit from multidisciplinary expertise, specialized transplant assessment, coordinated treatment planning, and structured follow-up.
The overall cost depends on the underlying diagnosis, transplant type, donor requirements, conditioning treatment, hospitalization, medications, supportive care, and follow-up.
Because transplant requirements vary significantly between patients, this service is offered at Price on Request following appropriate medical review.
Stem cell transplantation may be considered for selected blood cancers, bone marrow disorders, and other serious hematological conditions when clinically appropriate.
Autologous transplantation uses the patient's own stem cells, while allogeneic transplantation uses stem cells from a suitable donor.
Potential donors are evaluated for compatibility and medical suitability. The most appropriate donor depends on the patient's condition and available donor options.
Patients require close monitoring of blood counts, immune recovery, infection risk, organ function, treatment response, and potential transplant-related complications.
International patients may be considered subject to applicable eligibility, referral, appointment, and hospital requirements. Comprehensive medical and transplant records may be required for assessment.
Product Name: Stem Cell Transplantation at Karolinska University Hospital
Hospital: Karolinska University Hospital
Brand: Karolinska University Hospital
Country: Sweden
Location: Stockholm, Sweden
Specialty: Hematology & Blood Disorders
Service Type: Stem Cell Transplantation
Customer-Facing Price: Price on Request
International Patients: Subject to applicable eligibility and appointment requirements
Frequently Bought Together
Products from this Seller
View All
Subscribe our newsletter for coupon, offer and exciting promotional discount..
Share with Friends
Trading is more effective when you share products with friends!Share you link
Share to